1.The Relationship between Prevalence of Osteoporosis and Proportion of Daily Protein Intake.
Junga KIM ; Byungsung KIM ; Hani LEE ; Hyunrim CHOI ; Changwon WON
Korean Journal of Family Medicine 2013;34(1):43-48
BACKGROUND: The association between daily protein intake and osteoporosis is still controversial and only a few studies have explored the issue in Korea. This study investigated the relationship between daily protein intake and the prevalence of osteoporosis in Korean adults. METHODS: This study analyzed data extracted from the Korean National Health and Nutrition Examination Survey 4. Participants were aged 19 years or older and had never been treated for osteoporosis. The percentage of calories coming from protein intake was assessed by 24-hour recall method, and participants were divided into three groups according to recommended daily dietary protein intake as a proportion of total daily calories (i.e., <10%, 10%-20%, and >20%). A lumbar or femur neck bone mineral density T-score less than -2.5 was indicative of the presence osteoporosis. The influence of daily protein intake on the prevalence of osteoporosis was analyzed. RESULTS: In both sexes, the group with the highest protein intake had significantly lower odds of developing lumber osteoporosis when compared to the group with the lowest protein intake, after adjusting for associated factors (females: odds ratio [OR], 0.618; 95% confidence interval [CI], 0.610 to 0.626; P for trend <0.001; males: OR, 0.695; 95% CI, 0.685 to 0.705; P for trend <0.001). CONCLUSION: Sufficient daily protein intake lowered the prevalence of osteoporosis in Korean adults. Further prospective studies are necessary to verify the preventive effect of adequate protein intake on osteoporosis.
Adult
;
Aged
;
Bone Density
;
Dietary Proteins
;
Femur Neck
;
Humans
;
Korea
;
Nutrition Surveys
;
Odds Ratio
;
Osteoporosis
;
Prevalence
;
Proteins
2.Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment.
Hani YOO ; Jin A LEE ; Sohee OH ; Young Hwa JUNG ; Jin A SOHN ; Seung Han SHIN ; Chang Won CHOI ; Ee Kyung KIM ; Han Suk KIM ; Beyong Il KIM
Journal of Korean Medical Science 2017;32(1):115-123
The aim of this study was to assess the differences in the mortality and in-hospital outcomes of preterm infants with < 28 weeks of gestation who received ibuprofen treatment according to the presence of clinical symptoms (any of oliguria, hypotension, or moderate to severe respiratory difficulty) attributable to hemodynamically-significant patent ductus arteriosus (hsPDA) at the time of first ibuprofen treatment. In total, 91 infants born from April 2010 to March 2015 were included. Fourteen infants (15.4%) received ibuprofen treatment when there were clinical symptoms due to hsPDA (clinical symptoms group). In clinical symptoms group, infants were younger (25 [23–27] vs. 26 [23–27] weeks; P = 0.012) and lighter (655 [500–930] vs. 880 [370–1,780] grams; P < 0.001). Also, the clinical risk index for babies (CRIB)-II scores were higher and more infants received invasive ventilator care ≤ 2 postnatal days. More infants received multiple courses of ibuprofen in clinical symptoms group. Although the frequency of secondary patent ductus arteriosus (PDA) ligation and the incidence of bronchopulmonary dysplasia (BPD) was higher in the clinical symptoms group in the univariate analysis, after multivariate logistic regression analysis adjusting for the CRIB-II score, birthweight, birth year, and the invasive ventilator care ≤ 2 postnatal days, there were no significant differences in mortality, frequency of secondary ligation and in-hospital outcomes including necrotizing enterocolitis (NEC), intraventricular hemorrhage (IVH), BPD or death. Our data suggest that we can hold off on PDA treatment until the clinical symptoms become prominent.
Bronchopulmonary Dysplasia
;
Ductus Arteriosus, Patent*
;
Enterocolitis, Necrotizing
;
Hemorrhage
;
Humans
;
Hypotension
;
Ibuprofen*
;
Incidence
;
Infant
;
Infant, Newborn
;
Infant, Premature*
;
Ligation
;
Logistic Models
;
Mortality*
;
Oliguria
;
Parturition
;
Patient Outcome Assessment
;
Pregnancy
;
Ventilators, Mechanical
3.Serial Changes of Cytokines in Children with Cerebral Palsy Who Received Intravenous Granulocyte-colony Stimulating Factor Followed by Autologous Mobilized Peripheral Blood Mononuclear Cells.
Hani KOH ; Wee Jin RAH ; Yong Joo KIM ; Jin Hwa MOON ; Mi Jung KIM ; Young Ho LEE
Journal of Korean Medical Science 2018;33(21):e102-
BACKGROUND: This study was performed to assess serial cytokine changes and their clinical impact in children with cerebral palsy (CP) who received granulocyte-colony stimulating factor (G-CSF) followed by infusion of autologous mobilized peripheral blood mononuclear cells (mPBMCs). METHODS: Peripheral blood (PB) samples were collected from 16 CP children at enrollment, and 1 month and 7 months after G-CSF infusion as well as at the end of the study. Cytokine levels were measured by enzyme-linked immunosorbent assays with plasma samples. RESULTS: There were no significant differences in cytokine levels between the mPBMC and placebo groups over 6 months. However, when clinical responders and non-responders were compared, interleukin (IL)-6 (P = 0.050) as well as G-CSF (P = 0.010) were higher in the responders than the non-responders at 1 month, while brain-derived neurotrophic factor (BDNF) (P = 0.030) and insulin-like growth factor (IGF)-1 (P = 0.001) were lower. In addition, BDNF was higher at baseline in the responders than the non-responders (P = 0.030). CONCLUSION: The changes of G-CSF itself, as well as G-CSF-induced cytokines such as IL-6, may be associated with the clinical improvement of neurologic functions. The G-CSF-induced changes of IL-6, BDNF and IGF-1, and BDNF levels before treatment, could be used as prognostic factors in G-CSF trials in CP children.
Brain-Derived Neurotrophic Factor
;
Cerebral Palsy*
;
Child*
;
Cytokines*
;
Enzyme-Linked Immunosorbent Assay
;
Granulocyte Colony-Stimulating Factor
;
Humans
;
Insulin-Like Growth Factor I
;
Interleukin-6
;
Interleukins
;
Plasma
4.Differences in Mobilization Efficiency between Small Children and Adults with Healthy Marrows
Eun Kyung SHIN ; Do Yeon KIM ; Wee Jin RAH ; Hani KOH ; Jin Young SUH ; Misoo CHANG ; Eunwoo NAM ; Young Ho LEE
Clinical Pediatric Hematology-Oncology 2017;24(2):130-135
BACKGROUND: We compared the yields of mobilized PBSCs from single day of normal volume leukapheresis (NVL) in children and adults, and factors affecting the yields, to understand differences in mobilization efficiency between adults and small children with healthy marrows.METHODS: This study involved 18 adult volunteer donors and 47 small children weighing less than 20 kg who participated in a clinical trial of cell therapy in children with cerebral palsy. Donor factors analyzed to identify predictors of the yield of apheresis included age, gender, weight and complete blood cell count (CBC) with differential counts as well as equipment parameters.RESULTS: The yields of total nucleated cells (TNCs) and CD34⁺cells in the apheresis products of the children were significantly lower than in those from healthy adults. However, the efficiency of recovery of PBSCs (total CD34⁺ cell counts/TNCs) was significantly higher in small children (0.48±0.30%) than in adults (0.10±0.05%) (P < 0.05). Multivariable analysis of adult donor factors showed that the processed volume and flow rate of apheresis were significantly associated with the yield of TNCs (P < 0.05, for both), but not of CD34⁺cells. However, in multivariable analysis of child donor factors, body weight and circulating WBC count on the day of apheresis were significantly associated with the yield of TNCs (P < 0.05, for both) and of CD34⁺cells (P < 0.05, for both).CONCLUSION: The predictors of PBSC yields from a single day of NVL in adults and small children are different. Also mobilization is more effective in small children than in adults.
Adult
;
Blood Cell Count
;
Blood Component Removal
;
Body Weight
;
Bone Marrow
;
Cell- and Tissue-Based Therapy
;
Cerebral Palsy
;
Child
;
Hematopoietic Stem Cell Mobilization
;
Humans
;
Leukapheresis
;
Tissue Donors
;
Volunteers
5.A Survey on Customers' Perceptions of Nutrition Labeling for Processed Food and Restaurant Meal.
Kwang Il KWON ; Sung Won YOON ; So Jin KIM ; Hani KANG ; Hae Na KIM ; Jee Young KIM ; Seo Young KIM ; Killye KIM ; Jun Hyung LEE ; Sun Mi JUNG ; So Won OCK ; Eun Ju LEE ; Jong Wook KIM ; Myung Chul KIM ; Hye Kyung PARK
The Korean Journal of Nutrition 2010;43(2):181-188
Consumer perception of processed food and restaurant food's nutrient labelling was surveyed. The subjects of this survey consisted of 1,507 parents, whose ages were 20-59 years old. The ratio of the respondents that have known nutrition labelling on processed foods was 89.8% and the ratio of whom have checked the nutrition labelling at their point of purchase was 72.3%. The nutrients which were considered important for nutrition labelling were fat (57.1%), calorie (56.3%) and sodium (49.0%). Also nutrient which were able to be recognized at a glance by the subjects were in the order of trans fat (62.1%), cholesterol (26.9%), calorie (23.9%) and sodium (21.0%). If restaurant menu's nutrient labelling be enacted, the answer rate that the menu's nutrition labelling may affect their menu choice is 90.6% of the respondents. Besides of the Fastfoods that are enforcement, restaurants of that customers want the menu to be labeled were 'pizza and chicken restaurants'. Nutrients that customers preferred to be labelled were calorie (62.0%), fat (60.3%) and sodium (50.9%).
Chickens
;
Cholesterol
;
Food Labeling
;
Humans
;
Meals
;
Parents
;
Restaurants
;
Sodium
;
Surveys and Questionnaires
6.Structural and Functional Alterations at Pre-Epileptic Stage Are Closely Associated with Epileptogenesis in Pilocarpine-induced Epilepsy Model.
Hani KIM ; Yunsook CHOI ; Hye Young JOUNG ; Yun Seo CHOI ; Hyeon Jin KIM ; Yohan JOO ; Jin Hwan OH ; Hoo Jae HANN ; Zang Hee CHO ; Hyang Woon LEE
Experimental Neurobiology 2017;26(5):287-294
Pilocarpine-induced rat epilepsy model is an established animal model that mimics medial temporal lobe epilepsy in humans. The purpose of this study was to investigate neuroimaging abnormalities in various stages of epileptogenesis and to correlate them with seizure severity in pilocarpine-induced rat epilepsy model. Fifty male Sprague-Dawley rats were subject to continuous video and electroencephalographic monitoring after inducing status epilepticus (SE) and seizure severity was estimated by frequency and total durations of class 3 to 5 spontaneous recurrent seizures (SRS) by modified Racine's classification. The 7.0 Tesla magnetic resonance imaging (MRI) with high resolution flurodeoxyglucose positron emission tomography (FDG-PET) was performed at 3 hours, 1, 3, 7 days and 4 weeks after the initial insult. The initial SRS was observed 9.7±1.3 days after the pilocarpine injection. MRI revealed an abnormal T2 signal change with swelling in both hippocampi and amygdala in acute (day 1 after injection) and latent phases (days 3 and 7), in association with PET hypometabolism in these areas. Interestingly, the mean frequency of class 3 to 5 SRS was positively correlated with abnormal T2 signals in hippocampal area at 3 days. SRS duration became longer with more decreased glucose metabolism in both hippocampi and amygdala at 7 days after pilocarpine injection. This study indicates that development and severity of SRS at chronic phase could be closely related with structural and functional changes in hippocampus during the latent period, a pre-epileptic stage.
Amygdala
;
Animals
;
Classification
;
Epilepsy*
;
Epilepsy, Temporal Lobe
;
Glucose
;
Hippocampus
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Metabolism
;
Models, Animal
;
Neuroimaging
;
Pilocarpine
;
Positron-Emission Tomography
;
Rats
;
Rats, Sprague-Dawley
;
Seizures
;
Status Epilepticus
7.Effect of Intravenous Infusion of G-CSF-Mobilized Peripheral Blood Mononuclear Cells on Upper Extremity Function in Cerebral Palsy Children.
Kyeong Il PARK ; Young Ho LEE ; Wee Jin RAH ; Seung Hwi JO ; Si Bog PARK ; Seung Hoon HAN ; Hani KOH ; Jin Young SUH ; Jang soo UM ; Eun Hye CHOI ; Un Jin PARK ; Mi Jung KIM
Annals of Rehabilitation Medicine 2017;41(1):113-120
OBJECTIVE: To investigate the effect of intravenous infusion of peripheral blood mononuclear cells (mPBMC) mobilized by granulocyte-colony stimulating factor (G-CSF) on upper extremity function in children with cerebral palsy (CP). METHODS: Fifty-seven children with CP were enrolled. Ten patients were excluded due to follow-up loss. In total, 47 patients (30 males and 17 females) were analyzed. All patients' parents provided signed consent before the start of the study. After administration of G-CSF for 5 days, mPBMC was collected and cryopreserved. Patients were randomized into two groups 1 month later. Twenty-two patients were administered mPBMC and 25 patients received normal saline as placebo. Six months later, the two groups were switched, and administered mPBMC and placebo, respectively. Quality of Upper Extremity Skills Test (QUEST) and the Manual Ability Classification System (MACS) were used to evaluate upper motor function. RESULTS: All subdomain and total scores of QUEST were significantly improved after mPBMC and placebo infusion, without significant differences between mPBMC and placebo groups. A month after G-CSF, all subdomain and total scores of QUEST were improved. The level of MACS remained unchanged in both mPBMC and placebo groups. CONCLUSION: In this study, intravenously infused mPBMC showed no significant effect on upper extremity function in children with CP, as compared to placebo. The effect of mPBMC was likely masked by the effect of G-CSF, which was used in both groups and/or G-CSF itself might have other neurotrophic potentials in children with CP.
Cerebral Palsy*
;
Child*
;
Classification
;
Follow-Up Studies
;
Granulocyte Colony-Stimulating Factor
;
Humans
;
Infusions, Intravenous*
;
Male
;
Masks
;
Parents
;
Peripheral Blood Stem Cell Transplantation
;
Upper Extremity*
8.Clinical Applicability of Newly Developed Image-based Cell Counter for Counting CD34+ Cells: Comparison with Flow Cytometric Analysis
Wee Jin RAH ; Eun Kyung SHIN ; Hani KOH ; Jin Young SUH ; Misoo CHANG ; Eunwoo NAM ; Jong Hyun OH ; Yumi JUNG ; Ji Yeon LEE ; Sung Rok BONG ; Sung Hun HONG ; Jee Young KIM ; Sunmi HAN ; Jeoung Ku HWANG ; Chanil CHUNG ; Young Ho LEE
Clinical Pediatric Hematology-Oncology 2016;23(2):125-132
BACKGROUND: Flow cytometric analysis is the standard method for enumerating CD34+ stem cells in hematopoietic stem cell transplantation. However, it has some limitations such as expensive instrumentation, high reagent costs, and discrepancies between technicians and laboratories. We compared counts of total nucleated cells (TNCs) and CD34+ cells counts obtained from a flow cytometer with a newly-developed image-based microscopic cell counter (ADAM II) to evaluate the possibility of clinical application of the ADAM II.METHODS: We used 18 samples of circulating peripheral blood (PB) and waste tube fractions of peripheral blood stem cells (PBSCs) harvested by apheresis after G-CSF mobilization from adult volunteer donors. We assessed the reproducibility and linearity of the new procedure and compared the numbers of TNCs and viable CD34+ cells determined with the ADAM II and two different flow cytometers (FACSCalibur, FACSCanto II).RESULTS: Numbers of viable CD34+ cells determined with the ADAM II were accurate over the expected range; the intra-assay coefficient of variation was ≤19.8%. Linearity was also satisfactory (R²=0.99). TNC counts obtained with the ADAM II were highly correlated with those obtained with the FACSCalibur (R²>0.9841, P<0.0001) and FACSCanto II (R²>0.9620, P<0.0001), as were the numbers of viable CD34+ cells obtained with the ADAM II and the FACSCalibur and FACSCanto II (R²>0.9911, P<0.0001 and R²>0.9791, P<0.0001), respectively.CONCLUSION: The newly developed image-based microscopic cell counter (ADAM II) appears to be suitable for enumerating TNCs and viable CD34+ cells.
Adult
;
Blood Component Removal
;
Cell Count
;
Granulocyte Colony-Stimulating Factor
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Methods
;
Stem Cells
;
Tissue Donors
;
Volunteers